After Hours Summary: MU -2.4% falls on earnings and headcount reduction; MLKN +5.1% higher on earnings; MRTX +4.1% higher on positive FDA news; LXRX -8.4% falls on phase 2 study resultsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: MLKN +5.1%, BHR +2.4%
Companies trading higher in after hours in reaction to news: MRTX +4.1% (Adagrasib (KRAZATI) receives breakthrough therapy designation from FDA), TSP +2.1% (announces restructuring; to trim 25% of workforce, will focus on autonomous trucking tech), RAMP +2.1% (increases share repurchase program by $100 mln), GNL +1.4% (provides outlook on acquisitions), RTX +0.6% (awarded $413 mln U.S. Air Force contract), SMCI +0.2% (announces new ARM-based series of servers), PARR +0.1% (guides for 2023 CapEx; expects no material turnaround outlays during 2023)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: MU -2.4% (also to reduce headcount by 10% in CY23)
Companies trading lower in after hours in reaction to news: BLI -11.7% (to acquire IsoPlexis), LXRX -8.4% (topline results from Phase 2 study of LX9211), MTZ -1.2% (CFO to retire, names new CFO), UAA -1.1% (names new CEO), MDGL -1% (announces $300+ mln in financing events), MGI -0.4% (nearing completion of previously announced merger with Madison Dearborn, expects to close in Q1), REGN -0.2% (Dupixent Phase 3 results published in the NEJM)